Objective: To study the in¯uence of supplementation with antioxidants on factors, which might increase the risk of coronary heart disease (CHD) in Iranians. Design: Twenty-one male volunteers enter the prospective, single-blind, randomized study. Setting: The supplementation was conducted at the Cardiovascular Center, University of Tehran, the biochemical analysis were carried out in the University of Graz. Subjects: Twenty-one male medical students were recruited by advertisement. Five subjects were dropped out due to lack of the compliance. Methods: One group of Iranians received 30 mg/d b-carotene and placebo for a-tocopherol; the other received b-carotene plus 400 IU a-tocopherol for ten weeks. Concentrations of antioxidants in plasma and low density lipoproteins (LDL), plasma lipid pro®le, autoantibody against oxidized LDL (oLAb) and malondialdehyde (MDA) concentrations in plasma were measured. Oxidative resistance of LDL was estimated using conjugated diene assay. Results: Iranians had a signi®cantly lower plasma levels of total cholesterol (P`0.002), LDL-cholesterol (P`0.01) and high density lipoprotein-cholesterol (P`0.002), compared to healthy Austrian subjects (n 13). Although the baseline concentrations of a-tocopherol and b-carotene were comparable with Austrians, lycopene, canthaxanthin and lutein were signi®cantly higher in Iranians (P`0.03±0.001). In vitro oxidative resistance of LDL, measured as lag-time, was slightly higher (P`0.01) in Iranians comparing with Austrians. Plasma MDA and oLAb concentrations were signi®cantly higher in Iranians (P`0.001). Both dietary supplementations reduced plasma MDA concentrations (P`0.001±0.001). A key ®nding was that a supplement combined with atocopherol caused also a signi®cant increase of oLAb concentration (P b 0.01) as well as the signi®cant increase of lag-time (P b 0.005). Conclusions: This study shows that high plasma MDA level of Iranians can be decreased by b-carotene supplementation with or without a-tocopherol. However, a-tocopherol is a more powerful antioxidant, which can increase the resistance of LDL to oxidation, reduce the MDA concentrations in plasma and increase autoantibodies to oLDL.
Introduction
A high Coronary Heart Disease (CHD) mortality rate has been reported in Eastern Mediterranean Region including Iran (WHO, 1995) . It is varied from 25±45% of total death. This is also con®rmed by the report obtained from the National Center for Health Statistics (1991) . The premature CHD is often observed in male subjects under forty years of age, in Iran. There are no published data, regarding the risk factors for CHD, in international journals for a country such as Iran. However, the internal published reports and Ph.D. thesis suggested that the classic risk factors such as a high total cholesterol (T-CHO), triglyceride (TG) and LDL cholesterol, might be the underlying cause of this mortality (Keynejad & Saf®, 1993; Ajdari A, 1993, published in Persian) .
Oxidatively modi®ed LDL (oLDL) has been shown to be a causative factor in the development of atherosclerosis, because the accumulation of oLDL by macrophages leads to the subsequent formation of atherosclerotic plaques (Steinberg et al, 1989; Witzum & Steinberg, 1991) . Antibodies to oLDL are detectable in human plasma and may serve as important markers of oxidation . On the other hand, the resistance of LDL to oxidation depends on the balance between the polyunsaturated fatty acids (PUFA) and antioxidants Esterbauer et al, 1991a) , particularly a-tocopherol. Supplementation with a-tocopherol conferred the increased protection of LDL against in vitro oxidation (Jialal et al, 1995; Reaven et al, 1993) . The supplementation with bcarotene did not reveal a substantial improved oxidation resistance after the supplementation (Reaven et al, 1993; Princen et al, 1992) . However, in disease states associated with low resistance of LDL to oxidation such as cystic ®brosis, the supplementation with b-carotene resulted in a decrease in oxidation products (MDA) and an increased protection of LDL against in vitro oxidation (Winklhofer- Roob et al, 1995) . Also, several epidemiological studies suggest the relationships between dietary antioxidants and prevalence of CHD (Gey & Puska, 1989; Gaziano et al, 1995a) .
The aim of this study was to investigate the lipid pro®le and antioxidant concentrations in plasma and LDL of Iranian. As lipid pro®les have been reported only in few of the internal Iranian studies and the other analysis were performed here for the ®rst time on Iranian subjects, we compared them with the plasma and LDL parameters of Austrian subjects obtained under the same experimental conditions. Another target of the study was to investigate the effect of b-carotene supplementation, with or without atocopherol, on the oxidation resistance of LDL in vitro and on the formation of MDA and concentration of oLAb.
Materials and methods

Subjects
Twenty-one healthy males were recruited from medical students, University of Tehran. Exclusion criteria included smokers. The volunteers had a similar low physical activity and had traditional Iranian diet. The informed consent was obtained from each subject before entering the study. We compared the data obtained from Iranians (n 21) with those from Austrians living in Graz (n 13). For comparison of oLAb and MDA, the data from other Austrian volunteers also living in Graz, were used (n 16, age 22± 33; n 40, age 20±35 y, respectively). All analyses were performed under the same experimental conditions using the same equipment.
Experimental design
Twenty-one adult healthy male undergraduate students (age 23±26 y) in Tehran were volunteered for this study. One group (n 10) was given b-carotene (30 mg/d) with placebo for a-tocopherol, another (n 11) was given b-carotene (30 mg/d) and a-tocopherol (400 IU/d) for 10 weeks. They were asked to take their supplements with a meal and continue with their normal food habits. Three subjects from the ®rst supplementary group and two from the second supplementary group were excluded due to non-compliance. The study started in early spring for all study, to avoid any seasonal changes.
Materials
All solvents and further speci®ed chemicals were of analytical grade and supplied by Merck (Darmstadt, Germany) or Sigma (USA). Econo-Pac 10 DG column was purchased from Bio-Rad (Hercules, CA, USA). Microtitration plates were supplied by Maxisorp (Nunc, Denmark). For supplementation in vivo, the natural b-carotene capsules (from Dunaliella Salina algae, in soy bean oil contained a trace of a-tocopherol) and RRR-a-tocopherol capsules (in soy bean oil) were supplied free of charge by Lambert Healthcare Ltd, (UK). Placebo capsules for a-tocopherol containing soy bean oil were supplied free of charge by Henkel Ltd (Cork, Ireland).
Methods
Determination of lipid pro®les in serum. Cholesterol was measured by the CHOD-PAP method, TG by the GPO-PAP method, HDL-cholesterol was determined after separation using phosphotungstic acid and magnesium chloride. All using established kit methods were from Boehringer-Mannheim, Germany. LDL-cholesterol concentration was calculated by Friedewald equation (Friedewald et al, 1972) . The methods and results were validated against the UK-NEQAS scheme.
Storage of plasma and isolation of LDL. Blood samples were obtained by venipuncture. Serum was obtained for analyses of lipid pro®le. Blood samples containing 1 mg/ml EDTA, pH 7.4, were centrifuged at 3000 rpm for 10 min at 20 C. Sucrose solution was then added to the plasma samples to give a ®nal concentration of 0.6% to stabilize frozen lipoproteins . The plasma samples of Austrian and Iranian were treated in the same way. It has been shown that these storage conditions do not in¯uence the oxidation resistance and vitamin E content of LDL. The aliquots of plasma were stored at 780 C for a maximum of three months. Plasma samples were thawed and LDL was isolated by ultracentrifugation using a singlestep discontinuous gradient in a Beckman NVT 65 rotor at 60 000 rpm for 2 h at 10 C (Gieseg & Esterbauer, 1994) .
Determination of fat soluble antioxidants. Antioxidants were determined as has previously been described by Ziouzenkova et al, 1996 . Brie¯y, 0.5 mg LDL in 0.5 ml double distilled water or 200 ml of plasma with 200 ml of water were mixed with an equal volume of ice-cold ethanol (containing 0.5 mg/ml butylated hydroxytoluene). 1 ml of n-hexane was added and after centrifugation (3000 rpm, 5 min), 0.8 ml samples of hexane phase were dried under nitrogen. The residue was dissolved in a mixture of ethanol: ethylacetate (10:1 v/v). The antioxidants were analyzed by HPLC on a Merck Lichrocart 125-4, Lichrospher 100 RP-18 (5 mm) column using as the solvent acetonitrile:methanol:ethanol:water (60:50:20:2 v/v) to which 0.01% ammonium acetate was added. A¯uorescence detector (Jasco 821 FP) set at Ex/Em 292/335 nm was used for the determination of a-tocopherol and g-tocopherol, and set at Ex/Em 325/500 nm for retinol. Carotenoids were determined with a UV-VIS detector (L4250, Merck, Hitachi) set at 450 nm. The intra-assay coef®cient of variation was ranged between 4±7% for all antioxidants.
Oxidative resistance of LDL. Before oxidation, LDL was desalted and made EDTA free by a gel-®ltration using Econo-Pac columns, with 10 mmol phosphate buffer saline (PBS) pH 7.4 containing 0.15 M sodium chloride as the eluting buffer (Esterbauer et al, 1991b; Puhl et al, 1994) . The LDL concentration in PBS was determined by measuring of total cholesterol. LDL concentration is expressed assuming the LDL molecular weight of 2.5 MDa and a cholesterol content of 31.6 w/w%. The LDL oxidation process was followed by recording of the conjugated diene (CD) absorption at 234 nm in a Beckman DU-640 spectrophotometer. Oxidation was started by adding freshly prepared aqueous solutions of CuSO 4 to a ®nal concentration of 1.6 mM at 30 C to a PBS solution containing 0.25 mg/ml LDL (equal to 50 mg protein/ml or 0.1 mM LDL). The recording of the 234 nm absorption was started immediately after the addition of CuSO 4 and at intervals of 4 min for a period of up to 4 h. The recorded absorption data were ®nally processed by a computer to give the CD vs time curves.
Determination of autoantibodies to oLAb. Determination of oLAb was performed by a method described earlier by . Brie¯y, human LDL (50 mg Enhanced plasma level of lipid peroxidation S Meraji et al protein/ml) in PBS, (pH 7.4), was oxidized with CuCl 2 at a ®nal concentration of 1.66 mM for 24 h. Microtitration plates were coated using a concentration of LDL at 5 mg protein/ml (250 ml/well, 1.25 mg protein) in phosphate carbonate buffer (pH 9.6) overnight. Unspeci®c binding sites were blocked with 1% bovine serum albumin (BSA) in PBS (pH 7.4) for 2 h at room temperature. The sera of the subjects were diluted 1:21 in PBS and incubated for 2 h at 37 C in the wells coated with oLDL. After washing, 100 ml of antihuman IgG horseradish peroxidase conjugate was added to each well and incubated for 45 min at room temperature. Tetramethylbenzidine was used as a chromogenic substrate. Absorption was read at 450 nm. The absorbance of samples collected before supplementation was taken as the 100% value for each subject. The measurements of oLAb obtained after supplementation were calculated as a percent of this value.
Determination of malondialdehyde (MDA) in plasma. The EDTA plasma samples were stored at 770 C until was determined by HPLC as described previously (Wong et al, 1987) .
Statistical analysis. The evaluation of results were performed by the following statistical methods: Austrian and Iranian subjects were compared using unpaired t-tests; the supplemented and nonsupplemented group were compared using paired t-test. The correlations were estimated using Pearson correlation test or linear regression analysis. A P value`0.05 was considered as signi®cant. All values shown in tables are expressed as mean AE s.d. All statistical analyses were performed using the computer software SPSS Rel. 6.1.2.
Results
Lipid pro®le, antioxidant levels in plasma and LDL of Iranian subjects The lipid pro®le of Iranians is shown in Table 1 . The young Iranian males had a signi®cantly lower total cholesterol (P`0.002), lower LDL-and HDL-cholesterol concentrations (P`0.01 and P`0.0001, respectively), and a similar level of TG in comparison to Austrian subjects, but the ratio of LDL/HDL cholesterol was similar in both groups. The comparison of oxidizability of LDL was performed in vitro (Table 2) . LDL oxidation in vitro was initiated by addition of 1.6 mM copper sulphate and followed by 234 nm absorption, which represents conjugated diene formation. Even though the maximum rate of CD formation was the same between these two groups, CD maximum was signi®cantly lower in Iranians than in Austrians (P`0.003). The oxidation resistance of LDL, measured as lag-time, was slightly, but signi®cantly higher in Iranians than Austrians (P`0.01). Autoantibodies against oxidized LDL and MDA concentrations in plasma were measured as a possible index for oxidation in vivo (Table 1) . Iranians had a signi®cantly higher concentration of oLAb (P b 0.001) and MDA (P b 0.0001) than Austrians.
Effect of supplementation with b-carotene Supplementation with b-carotene resulted in a 7±10-fold increase in the b-carotene concentrations of plasma and LDL (Tables 3 and 4 ). The other carotenoids (lutein zeaxanthin, b-cryptoxanthin, canthaxanthin, lycopene) were reduced in plasma by 1.8-fold. Although the bcarotene content was increased in LDL, there were no signi®cant changes in the lag-time as compared to the baseline values (Table 4) . However there was a signi®cant correlation between the total carotenoid content of LDL and lag-time in the supplemented group (Figure 2 . About 75% of carotenoids was b-carotene). The content of atocopherol in LDL was not changed by supplementation with b-carotene (Table 4) and did not correlate with lag- Figure 1 Typical chromatogram of carotenoids in plasma indicating the concentration differences for Iranians (A) and Austrians (B). 1, Zeaxanthin Lutein; 2, Canthaxanthin; 3, Cryptoxanthin; 4, Lycopene; 5, a-Carotene; 6, b-Carotene. 
Effect of supplementation with b-carotene and a-tocopherol (combined antioxidants)
Combined supplementation resulted in a signi®cant increase in b-carotene and a-tocopherol in LDL and plasma (P`0.011±0.003) (Tables 3, 4). Although both supplemented groups ingested the same amount of bcarotene, the enhancement of LDL and plasma b-carotene concentrations in the combined group was approximately 50% lower in comparison with those taking b-carotene alone. The other carotenoids were signi®cantly reduced, both in plasma and LDL (P`0.03±0.001) ( Table 4) . The combined supplementation resulted in an increased lag-time which was positively correlated to a-tocopherol content of LDL (P`0.001, Figure 3 ), but there was no correlation between total carotenoids and lag-time after combined supplementation.
Effect of the supplementation on oLAb and MDA Supplementation with b-carotene was not associated with any change in circulating antibodies against oLDL. However, the combined supplementation resulted in a signi®-cant increase in circulating oLAb (P`0.01, Table 3 ). bCarotene supplementation with or without a-tocopherol led to a signi®cant reduction of MDA concentrations in plasma (P`0.001, Table 3 ). Plasma MDA concentrations were inversely correlated with plasma b-carotene concentrations in group on b-carotene supplementation alone (P`0.001, Figure 4 ). In the group taking combined supplementation, b-carotene was not correlated with MDA concentrations in plasma, but there was a correlation with plasma a-tocopherol concentrations (P`0.008, Figure 5 ). Enhanced plasma level of lipid peroxidation S Meraji et al
Discussion
Iranian reports indicate that the classic risk factors, such as abnormal lipid pro®le, might be responsible for the high CHD mortality in this country (Keynejad & Saf®, 1993; WHO, 1995) . The comparison of lipid pro®le between Iranians and Austrians showed that Iranians had signi®-cantly lower total cholesterol and LDL-cholesterol levels which were within the range recommended for this age group (Sheperd & Fruchart, 1989) . The HDL-cholesterol was very low, however, LDL/HDL ratio, known as a main classic atherogenic risk factor, was similar between these two groups. Thus, Iranian did not show an abnormal lipid pro®le except that their HDL level was low. The antioxidant hypothesis suggests that the suboptimal level of antioxidants can be relevant to the development of CHD (Gey, 1995) . Despite the different dietary habit of Iranians, the concentrations of a-tocopherol, the main plasma and LDL antioxidant, and also b-carotene were comparable to those of Austrians. However, the concentrations of lycopene, canthaxanthin, lutein zeaxanthin were higher in Iranians than in Austrians. This ®nding is probably due to the large consumption of tomatoes and green vegetables, particularly herbs (dill weed, watercress, mint, parsley, green onions) which contain a high amount of these carotenoids. For example, the traditional daily consumption of herbs is about 200 g in Iran. Concentrations of a-tocopherol and b-carotene in plasma were comparable with those of Austrians (Table 1) . Moreover, the levels of these antioxidants were also similar to the concentrations which were proposed by Gey as suf®cient for a-tocopherol (5.2 mmol/mmol cholesterol vs 5.5 found in this study) and b-carotene (0.4 mmol/L). Despite that, a high level of MDA was found in their plasma. The ratio of vitamin E/PUFA was suggested to be more important than the total amount of vitamin E in plasma (Gey, 1995) . The presence of a high proportion of polyunsaturated fatty acids (PUFA), in spite of normal concentration of vitamin E in plasma, may lead to an increase of MDA level in Iranian subjects but this remains to be determined.
b-Carotene and a-tocopherol have been shown to be very effective antioxidants especially with respect to inhibition of MDA formation. Some investigators demonstrate that supplementation with b-carotene (Dixon et al, 1994; Winklhofer-Roob et al, 1995) resulted in a decrease of plasma MDA concentration. Supplementation with a-tocopherol (Jialal & Grundy, 1992) showed a decrease of MDA formation during the copper-mediated oxidation. The potential effect of these antioxidants may be dependent on the degree of unsaturation in fatty acid, as suggested by Bartoli et al, 1995 . The present study showed that the supplementation either with b-carotene alone or combined with a-tocopherol could signi®cantly reduce the high plasma MDA concentrations in Iranians (Table 3) . However, a high inverse correlation was achieved between plasma and MDA and b-carotene (P`0.001, Figure 4 ) in b-carotene supplementation alone: with combined supplementation MDA correlated inversely with a-tocopherol (P`0.008, Figure 5 ).
Despite a 10-fold increase in b-carotene concentration in LDL following supplementation, the oxidation resistance of LDL was not improved (Table 4 ). The lag-time obtained in Cu 2 -mediated LDL oxidation remained the same. However, we cannot exclude the possibility that carotenoids can moderately in¯uence the lag-time, as there was a signi®cant correlation between all carotenoids and lag-time after supplementation with b-carotene (r 2 0.714, P`0.017; Figure 2 ). Princen et al, 1992 , have reported that any increase in LDL lag-time was observed, despite the massive increase in LDL b-carotene after supplementation. However, these healthy subjects also had a high basal lag-time (100 min) as was shown in this study.
In contrast, a-tocopherol in combination with b-carotene showed a potent antioxidative effect. The lag-time was signi®cantly increased after supplementation due to an increase of a-tocopherol in LDL (Table 4 ). This is revealed by a high positive correlation between lag-time and atocopherol content of LDL (Figure 3) . Neither b-carotene, which was increased ®ve fold after this combined supplementation, nor all carotenoids, had any effect on lagtime. In combined supplementation the decrease of plasma MDA concentrations may be due to the antioxidative effect of a-tocopherol, because a high inversely correlation between these parameters was observed (P b 0.008, Figure 5) .
The decreased MDA level, following the combined antioxidant supplementation, was associated with an increased titre of circulating autoantibodies to oLDL. As reported previously, the inverse correlation was found between the concentration of oLAb and age . Furthermore, a transient reduction of oLAb was found in patients during acute myocardial infarction (Schumacher et al, 1995) . A high titer of circulating oLAb was observed in children compared to adults. In all these observations, increased concentrations of oLAb were present in association with low levels of lipid peroxidation. This can be explained by the removal of oxidation products and oxidatively damaged particles by cells of the immune system . Thus, the increase in oLAb level which was observed after supplementation with a-tocopherol, could be ascribed to the protective effect of a-tocopherol on lipid peroxidation in vivo rather than to a prooxidative effect of a-tocopherol which was found under speci®c conditions in vitro (reviewed in Bowry & Stocker, 1993) . To our knowledge, this is the ®rst study on the effect of antioxidant supplementation on oLAb. Further studies on larger cohorts are needed for clari®cation. 
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Another interesting aspect of the supplementation with lipophilic antioxidants was the effect on the content of endogenous antioxidants, primarily carotenoids. Supplementation with b-carotene increased the b-carotene content in plasma and LDL, but the signi®cantly decreased content of other plasma carotenoids (Tables 3 and 4) . A decrease of lycopene in plasma was also reported by Micozzi et al, 1992 , after short-time (six weeks) supplementation with 30 mg/d b-carotene. Similarly, lycopene content of LDL was decreased after 6 d supplementation with 100 mg bcarotene (Gaziano et al, 1995b) . In contrast long-time supplementation (12 y) did not affect concentration of other carotenoids (Fotouhi et al, 1996) . Interestingly, the plasma concentrations reported by Fotouhi and coworkers were very similar to those observed in Austrians (mmol/L: 0.39 vs 0.32 for lycopene, 0.28 vs 0.32 for b-crypthoxanthin, and 0.44 vs 0.47 for lutein zeaxanthin, respectively) and therefore substantially lower than in Iranians. The reduction of other carotenoids after supplementation with b-carotene in this study may be due to the high basal level of these carotenoids and/or to differences in length of supplementation. The supplementation with b-carotene and a-tocopherol, also signi®cantly reduced the concentrations of the other carotenoids in both plasma and LDL. Moreover, the increase in b-carotene concentrations after this supplementation was not as high as in the group supplemented with b-carotene alone. A substantially lower total carotenoid level has been also reported by Willet et al, 1983 , among subjects receiving b-carotene and a-tocopherol simultaneously compared to subjects receiving bcarotene alone. This complex relationship suggests competition between these lipophilic antioxidants. The nature and site of any such effects remain to be determined. So the supplementation containing a variety of the main carotenoids and tocopherols seems to be more reasonable: on one hand they have multiple antioxidant effects; on the other hand the decrease in concentrations of other important carotenoids could be avoided.
